Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25271, first published .
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

Fabio Efficace 1, PhD;  Massimo Breccia 2, MD;  Paola Fazi 1, MD;  Francesco Cottone 1, PhD;  Bernhard Holzner 3, 4, PhD;  Marco Vignetti 1, MD

1 Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA) , Rome , IT

2 Department of Precision and Translational Medicine, Sapienza University , Rome , IT

3 University Hospital of Psychiatry II, Medical University of Innsbruck , Innsbruck , AT

4 Evaluation Software Development Ltd , Innsbruck , AT

Corresponding Author:

  • Fabio Efficace, PhD
  • Data Center and Health Outcomes Research Unit
  • Italian Group for Adult Haematologic Diseases (GIMEMA)
  • via Casilina 5
  • Rome
  • IT
  • Phone: 39 06441639831
  • Email: f.efficace@gimema.it